ID Name Structure References (top 5) Molecular Target(s)
1ID:4848
OLEIC ACID


NSC#:9856
NSC#:26988
NSC#:65522
NSC#:112237
NSC#:112238
Aldrich#:268046
Aldrich#:364525
Aldrich#:45089
Aldrich#:45090
Aldrich#:490423
Aldrich#:490431
Aldrich#:75090
Aldrich#:75092
Aldrich#:75093
Aldrich#:75096
Aldrich#:E304
Aldrich#:E4637
Aldrich#:O1008
Aldrich#:O1383
Aldrich#:O1508
Aldrich#:O1630

Freqency:
in 16 ingredients:

  • 5
  • 13
  • 20
  • 62
  • 63
  • 102
  • 179
  • 253
  • 282
  • 295
  • 394
  • 416
  • 464
  • 479
  • 599
  • 618
  • in 100 recipes:

  • 3
  • 4
  • 5
  • 8
  • 18
  • 20
  • 21
  • 26
  • 30
  • 33
  • 40
  • 51
  • 53
  • 55
  • 64
  • 66
  • 67
  • 68
  • 69
  • 71
  • 73
  • 75
  • 77
  • 78
  • 89
  • 100
  • 101
  • 106
  • 107
  • 108
  • 114
  • 120
  • 126
  • 128
  • 135
  • 140
  • 146
  • 147
  • 153
  • 158
  • 166
  • 167
  • 168
  • 172
  • 173
  • 174
  • 180
  • 183
  • 198
  • 203
  • 206
  • 208
  • 209
  • 212
  • 221
  • 224
  • 230
  • 231
  • 232
  • 236
  • 241
  • 245
  • 251
  • 252
  • 258
  • 262
  • 264
  • 270
  • 282
  • 284
  • 285
  • 288
  • 289
  • 290
  • 291
  • 292
  • 295
  • 299
  • 303
  • 308
  • 311
  • 312
  • 313
  • 316
  • 317
  • 318
  • 319
  • 320
  • 321
  • 323
  • 325
  • 326
  • 327
  • 331
  • 332
  • 343
  • 344
  • 345
  • 351
  • 354

  • Properties
    C18H34O2    282.46





    1:  Harper ME, Antoniou A, Villalobos-Menuey E, Russo A, Trauger R, Vendemelio M, George A, Bartholomew R, Carlo D, Shaikh A, Kupperman J, Newell EW, Bespalov IA, Wallace SS, Liu Y, Rogers JR, Gibbs GL, Leahy JL, Camley RE, Melamede R, Newell MK.
    Characterization of a novel metabolic strategy used by drug-resistant tumor cells.
    FASEB J.    impact factor:   11.88
    2002;  16(12): 1550-7

    2:  Doolan GK, Panchal RG, Fonnes EL, Clarke AL, Williams DA, Petrou S.
    Fatty acid augmentation of the cardiac slowly activating delayed rectifier current (IKs) is conferred by hminK.
    FASEB J.    impact factor:   11.88
    2002;  16(12): 1662-4

    3:  Lanza GM, Yu X, Winter PM, Abendschein DR, Karukstis KK, Scott MJ, Chinen LK, Fuhrhop RW, Scherrer DE, Wickline SA.
    Targeted antiproliferative drug delivery to vascular smooth muscle cells with a magnetic resonance imaging nanoparticle contrast agent: implications for rational therapy of restenosis.
    Circulation.    impact factor:   9.903
    2002;  106(22): 2842-7

    4:  Gomez R, Navarro M, Ferrer B, Trigo JM, Bilbao A, Del Arco I, Cippitelli A, Nava F, Piomelli D, Rodriguez de Fonseca F.
    A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding.
    J Neurosci.    impact factor:   8.955
    2002;  22(21): 9612-7

    5:  Litvak V, Shaul YD, Shulewitz M, Amarilio R, Carmon S, Lev S.
    Targeting of Nir2 to lipid droplets is regulated by a specific threonine residue within its PI-transfer domain.
    Curr Biol.    impact factor:   8.733
    2002;  12(17): 1513-8

     
    Time used: 141 milliseconds.

    Webpage designed by Dr. Xueliang Fang, last updated on 3/10/2005